🧬 "We make tests intelligent by connecting laboratory results to a patient’s own clinical data" 📡 Tempus AI a health tech company, that provides "AI-enabled precision medicine" filed for an IPO with the SEC on May 21 -Founded in 2015, Tempus has developed the world's largest library of clinical and molecular data and an operating system for precision medicine. -They focus on AI-enabled diagnostics across various fields including cardiology, neuropsychology, and radiology and their Platform can ingest real-time healthcare data to personalize diagnostics. -Its services are utilized by 95% of the largest public pharmaceutical companies and over 7,000 physicians. -Tempus' platform connects providers through "dedicated data pipelines that create a network of healthcare institutions through approximately 450 unique data connections across more than 2,000 healthcare institutions." -Tempus has partnered with major pharmaceutical companies such as Pfizer, GSK, and AstraZeneca.
CO/AI’s Post
More Relevant Posts
-
The Digital Medicine Society has joined forces with leading pharmaceutical companies for a groundbreaking project focused on new digital endpoints. This collaboration aims to provide individuals with the necessary resources to effectively present their case. The initial phase involves developing a comprehensive value framework for digital endpoints, followed by the creation of a business case model and forecasting tools. Exciting advancements are on the horizon as the partners work towards enhancing the utilization of digital endpoints in healthcare. #DigitalHealth #Innovation
Digital Medicine Society partners with pharma giants for new digital endpoints project
fiercebiotech.com
To view or add a comment, sign in
-
Emergent Disruptions in Theranostics Industry in 2024 – Market Trends and Technology Read More :- https://lnkd.in/dep6HvGw The #theranostics market, a fusion of therapy and diagnostics, is undergoing a transformative phase, marked by a surge in acquisitions totaling around $1.5 billion in the last two years. This growth trajectory is propelled by the increasing emphasis on #personalizedmedicine, where #diagnosticimaging plays a pivotal role in targeted therapy. With imaging giants like GE, Fuji, and Canon securing 180 patents from the FDA, the next 2-3 years promise a significant evolution for both #pharmaceutical manufacturers and #imaging leaders. #theranostics #precisionmedicine #personalizedtherapy #cancertreatment #moleculardiagnostics #biomarkers #diagnosticimaging #targetedtherapy #healthcareinnovation #medicaltechnology #diagnostics #therapeutics #drugdevelopment #precisiononcology #integratedmedicine #patientcare #biotechnology #clinicalresearch #innovativemedicine #healthtech
Emergent Disruptions in Theranostics Industry in 2024 Market Trends and Technology
marketsandmarkets.com
To view or add a comment, sign in
-
Astellas Pharma CEO Q&a (Part 2): We Have To Have Alternatives for Prescription Medicine Business – MedCity News - MedCity News #AstellasPharmaCEOQ&A: In this blog post from MedCity News, the CEO of Astellas Pharma discusses the need for alternatives in the prescription medicine business. The post is divided into several sections, each addressing a specific aspect of the interview. #DigitalTransformation: The CEO emphasizes the importance of digital transformation in healthcare and the pharmaceutical industry. He discusses how technology can improve patient care and outcomes. #Innovation: The CEO highlights the role of innovation in driving growth and success in the pharmaceutical sector. He emphasizes the need for continuous innovation to stay competitive. #PatientCentricity: The CEO stresses the importance of putting patients at the center of healthcare decision-making. He discusses how patient-centric approaches can lead to better outcomes and experiences ai.mediformatica.com #medcity #news #digital #innovation #medicine #pharma #prescription #about #busine #technology #digitaltechnologies #patients #digitalhealth #healthit #healthtech #healthcaretechnology @MediFormatica (https://buff.ly/4af2QbH)
Astellas Pharma CEO Q&a (Part 2): We Have To Have Alternatives for Prescription Medicine Business - MedCity News
https://medcitynews.com
To view or add a comment, sign in
-
AI-driven strategies is helping pharmaceutical companies overcome some of the biggest hurdles in patient recruitment for clinical trials. In his recent interview with Pharma Focus Europe, Dr. Santhosh Kumar shares exclusive insights on how AI/ML is used, to boost data-driven clinical trials design, improve site identification, and patient enrolment activities. Read the article by clicking the link below. #FutureReadyHealthcare
AI in Patient Recruitment | Data driven clinical trials
pharmafocuseurope.com
To view or add a comment, sign in
-
The 𝐓𝐡𝐞𝐫𝐚𝐧𝐨𝐬𝐭𝐢𝐜𝐬 𝐌𝐚𝐫𝐤𝐞𝐭, a fusion of therapy and diagnostics, is undergoing a transformative phase, marked by a surge in acquisitions totaling around $1.5 billion in the last two years. This growth trajectory is propelled by the increasing emphasis on personalized medicine, where diagnostic imaging plays a pivotal role in targeted therapy. With imaging giants like GE, Fuji, and Canon securing 180 patents from the FDA, the next 2-3 years promise a significant evolution for both pharmaceutical manufacturers and imaging leaders. Download PDF Brochure : https://lnkd.in/g4miH86R Theranostics market is projected to escalate from $2.1 billion in 2023 to $4.3 billion by 2028, the market is set to expand at a CAGR of 15.5%. This growth is underpinned by the rising establishment of hospitals, a shift towards targeted therapies, and the introduction of novel theranostic approaches.
Emergent Disruptions in Theranostics Industry in 2024 Market Trends and Technology
marketsandmarkets.com
To view or add a comment, sign in
-
#SpeakingofScience: Prescription Digital Therapeutics (#PDTs) are software-based treatments that are evaluated for safety and efficacy in #clinicaltrials by the FDA. While PDTs have the potential to revolutionize the way we treat diseases, they are also changing the ways in which the #tech and #pharma industries intersect. This STAT News article explores how #bigtech and #bigpharma are fighting for the upper hand in this new market—and what this means for the future of #biotech. #personalizedmedicine #precisionmedicine https://lnkd.in/eJX6DC8s
Pharma can’t let Big Tech win the race for medical AI
https://www.statnews.com
To view or add a comment, sign in
-
Business Development Director | | Guiding People to Better Tomorrows | Empowering Success in Wellness and Wellbeing Coaching
What #patients should consider about #clinicaltrial ? Properly #translating the documentation required in a #clinicaltrial is a critical step for it to be safe for patients. First, participants must properly understand what the study entails and decide whether they want to participate. Then, they must comprehend and properly follow the instructions. https://lnkd.in/e76dww_c #safety #clinicaltrial #translation #compliance #pharmaceutical #lifesciences Avantpage Life Sciences Avantpage Translations
What patients should consider about clinical trials
https://wtop.com
To view or add a comment, sign in
-
https://lnkd.in/d7vYg_R5 Read about " Precision Medicine: Progressing Healthcare through Personalisation" written by the Dean Faculty of Science, Malir University of Science and Technology. #precisionmedicine #medicine #MedicalEducation #drsyedasadafakber #staravis #pharmaceutical #choicesmatter #maliruniversity #antibioticresistance
Precision Medicine: Progressing Healthcare through Personalization
https://www.staravis.com
To view or add a comment, sign in
-
Specialized Support for the Pharmaceutical, Biotechnology, Medical Device, and Related Health-Care Fields The Medical Science Liaison (MSL) is a specialized role within the pharmaceutical, biotechnology, medical device, and related healthcare fields. We concentrate on a specific therapeutic area or disease state (e.g., oncology, cardiology, gastroenterology, infectious diseases, rheumatology). MSLs establish and maintain relationships with leading physicians, researchers, and clinicians, referred to as key opinion leaders (KOLs) at academic institutions, hospitals, pharma companies, and others. We can help ensure that products are used effectively, serve as scientific resources and experts, advise on upcoming advances in treatments, and provide input about relevant scientific and clinical data. [📞 Connect with Us 704-266-3250| 🌐 Visit Our Website www.ccresearch.org #MSL #MedicalScienceLiaison #clinicalresearch #clinicaltrials #drdeirdreclark #ccresearch #medicine #research #healthcare #medicalresearch #clinicaltrial #science #clinical #health #clinicalstudies #pharma #medical #pharmacy #biotech #covid #biopharma #pharmaceuticals #clinicalstudy #pharmacovigilance #medicalaffairs #clinicalresearchassociate #pharmaindustry #doctor #pharmaceuticalindustry #phd #oncology #drugdevelopment #cra #biotechnology
MEDICAL SCIENCE LIAISON SERVICES
ccresearch.org
To view or add a comment, sign in
-
Ben Green, MD, our SVP of Services, shares his insights with Pharmaceutical Executive on how pharma and remote patient monitoring companies can work together to make decentralized clinical trials more commonly available. Read more below. #ClinicalTrials #ClinicalResearch #RPM #Pharma #DCT
The Rapid Growth of Remote Patient Monitoring Solutions Can Accelerate Decentralized Clinical Trials
pharmexec.com
To view or add a comment, sign in
1,782 followers
Digital Product Designer, Entrepreneur
1moThis seems like positive news on many fronts.